Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
ABSTRACT
About Foot and Mouth Disease Vaccine
FMD is a severe and contagious viral disease found in cloven-hoofed animals. FMD virus leads to illness in cows, sheep, pigs, goats, deer, and other animals with divided hooves. Animals with FMD will have fever and blisters on the tongue, lips, mammary glands, in and around the mouth, and around the hooves. These blisters pop and turn into red areas called erosions. These blisters cause pain and discomfort and will lead to other symptoms such as depression, excessive salivation, anorexia, lameness, and resistance to moving or stand. The disease weakens the animals and will affect the production of meat and milk.
Technavio’s analysts forecast the global foot and mouth disease vaccine market to grow at a CAGR of 8.61% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global foot and mouth disease vaccine market for 2017-2021. To calculate the market size, the report considers the revenue generated through applications such as cattle, pigs, sheep, goats, and others.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Foot and Mouth Disease Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Merck
• Brilliant Bio Pharma
• Indian Imumunologicals
• Biogénesis Bagó
• Boehringer Ingelheim
Other prominent vendors
• Bayer HealthCare
• Ceva
• Inovio Pharmaceuticals
• Plumbline Life Sciences
• SEPPIC
Market driver
• Frequent foot-and-mouth disease (FMD) outbreaks in Asia and the Middle East.
• For a full, detailed list, view our report
Market challenge
• Stringent government regulations coupled with adverse side effects.
• For a full, detailed list, view our report
Market trend
• Increasing preventive measures in FMD-free areas.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
About Foot and Mouth Disease Vaccine
FMD is a severe and contagious viral disease found in cloven-hoofed animals. FMD virus leads to illness in cows, sheep, pigs, goats, deer, and other animals with divided hooves. Animals with FMD will have fever and blisters on the tongue, lips, mammary glands, in and around the mouth, and around the hooves. These blisters pop and turn into red areas called erosions. These blisters cause pain and discomfort and will lead to other symptoms such as depression, excessive salivation, anorexia, lameness, and resistance to moving or stand. The disease weakens the animals and will affect the production of meat and milk.
Technavio’s analysts forecast the global foot and mouth disease vaccine market to grow at a CAGR of 8.61% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global foot and mouth disease vaccine market for 2017-2021. To calculate the market size, the report considers the revenue generated through applications such as cattle, pigs, sheep, goats, and others.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Foot and Mouth Disease Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Merck
• Brilliant Bio Pharma
• Indian Imumunologicals
• Biogénesis Bagó
• Boehringer Ingelheim
Other prominent vendors
• Bayer HealthCare
• Ceva
• Inovio Pharmaceuticals
• Plumbline Life Sciences
• SEPPIC
Market driver
• Frequent foot-and-mouth disease (FMD) outbreaks in Asia and the Middle East.
• For a full, detailed list, view our report
Market challenge
• Stringent government regulations coupled with adverse side effects.
• For a full, detailed list, view our report
Market trend
• Increasing preventive measures in FMD-free areas.
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
